{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:48:00Z","timestamp":1791308880651,"version":"4.3.1"},"reference-count":49,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[1998,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>To analyze the roles of interleukin-12 (IL-12) and the IL-12-dependent Th1 response in resistance to<jats:italic>Cryptococcus neoformans<\/jats:italic>, we have established a chronic infection model in wild-type mice and in mice with targeted disruptions of the genes for the IL-12p35 and IL-12p40 subunits (IL-12p35<jats:sup>\u2212\/\u2212<\/jats:sup>and IL-12p40<jats:sup>\u2212\/\u2212<\/jats:sup>mice, respectively) as well as in mice with a targeted disruption of the IL-4 gene. Long-term application of exogenous IL-12 prevented death of infected wild-type mice for the entire period of the experiment (up to 180 days) but did not resolve the infection. Infected IL-12p35<jats:sup>\u2212\/\u2212<\/jats:sup>and IL-12p40<jats:sup>\u2212\/\u2212<\/jats:sup>mice died significantly earlier than infected wild-type mice, whereas infection of IL-4-deficient mice led to prolonged survival. Interestingly, infected IL-12p40<jats:sup>\u2212\/\u2212<\/jats:sup>mice died earlier and developed higher organ burdens than IL-12p35<jats:sup>\u2212\/\u2212<\/jats:sup>mice, which, for the first time in an infection model, suggests a protective role of the IL-12p40 subunit independent of the IL-12 heterodimer. The fungal organ burdens of IL-4-deficient mice and IL-12-treated wild-type mice were significantly reduced compared to those of untreated wild-type mice and IL-12-deficient mice. Histopathological analysis revealed reduction of the number of granulomatous lesions following treatment with IL-12. Susceptibility of both IL-12p35<jats:sup>\u2212\/\u2212<\/jats:sup>and IL-12p40<jats:sup>\u2212\/\u2212<\/jats:sup>mice was associated with marginal production of gamma interferon and elevated levels of IL-4 from CD4<jats:sup>+<\/jats:sup>T cells, which indicates Th2 polarization in the absence of IL-12, whereas wild-type mice developed a Th1 response. Taken together, our data emphasize the essential role of IL-12 for protective Th1 responses against<jats:italic>C. neoformans<\/jats:italic>.<\/jats:p>","DOI":"10.1128\/iai.66.10.4994-5000.1998","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T15:21:00Z","timestamp":1577805660000},"page":"4994-5000","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":253,"title":["Interleukin-12 Is Essential for a Protective Th1 Response in Mice Infected with<i>Cryptococcus neoformans<\/i>"],"prefix":"10.1128","volume":"66","author":[{"given":"Klaus","family":"Decken","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Infectious Diseases, F. Hoffmann-La Roche AG, Basel, Switzerland1;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Ko\u0308hler","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Pathology, Albert Ludwig University, Freiburg, Germany2; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Palmer-Lehmann","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Infectious Diseases, F. Hoffmann-La Roche AG, Basel, Switzerland1;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Wunderlin","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Infectious Diseases, F. Hoffmann-La Roche AG, Basel, Switzerland1;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mattner","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Infectious Diseases, F. Hoffmann-La Roche AG, Basel, Switzerland1;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Magram","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Inflammation\/ Autoimmune Diseases, Hoffmann-La Roche Inc., Nutley, New Jersey3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice K.","family":"Gately","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Inflammation\/ Autoimmune Diseases, Hoffmann-La Roche Inc., Nutley, New Jersey3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried","family":"Alber","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Infectious Diseases, F. Hoffmann-La Roche AG, Basel, Switzerland1;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.5.1725-1731.1995"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.166.5.1229"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.3.460"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.1.39"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.3.1041"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(92)90322-G"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.5.1387"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.10.2683-2685.1997"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250133"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4049\/jimmunol.136.2.672","article-title":"Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity","volume":"136","author":"Granger D. L.","year":"1986","unstructured":"Granger D. L. Perfect J. R. Durack D. T. Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity.J. Immunol.1361986672680","journal-title":"J. Immunol."},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(78)90334-9"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.5.1505"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.4049\/jimmunol.137.11.3624","article-title":"Natural cellular resistance of beige mice against Cryptococcus neoformans","volume":"137","author":"Hidore M. R.","year":"1986","unstructured":"Hidore M. R. Murphy J. W. Natural cellular resistance of beige mice against Cryptococcus neoformans.J. Immunol.137198636243631","journal-title":"J. Immunol."},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.6.1685"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.4049\/jimmunol.152.5.2344","article-title":"CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans","volume":"152","author":"Hill J. O.","year":"1994","unstructured":"Hill J. O. Aguirre K. M. CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans.J. Immunol.152199423442350","journal-title":"J. Immunol."},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.755"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.17.6.2879"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.13.4.7546779"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8097338"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.4049\/jimmunol.160.5.2393","article-title":"IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL\/6)","volume":"160","author":"Huffnagle G. B.","year":"1998","unstructured":"Huffnagle G. B. Boyd M. B. Street N. E. Lipscomb M. F. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL\/6).J. Immunol.160199823932400","journal-title":"J. Immunol."},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.4049\/jimmunol.157.10.4529","article-title":"Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans","volume":"157","author":"Huffnagle G. B.","year":"1996","unstructured":"Huffnagle G. B. Toews G. B. Burdick M. D. Boyd M. B. McAllister K. S. McDonald R. A. Kunkel S. L. Strieter R. M. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.J. Immunol.157199645294536","journal-title":"J. Immunol."},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.4.793"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.4049\/jimmunol.159.11.5528","article-title":"IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production","volume":"159","author":"Kawakami K.","year":"1997","unstructured":"Kawakami K. Qureshi M. H. Zhang T. Okamura H. Kurimoto M. Saito A. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production.J. Immunol.159199755285534","journal-title":"J. Immunol."},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.4.1307-1312.1997"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1996.14723.x"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.3.827"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/362245a0"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4049\/jimmunol.158.4.1772","article-title":"Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans","volume":"158","author":"Lovchik J.","year":"1997","unstructured":"Lovchik J. Lipscomb M. Lyons C. R. Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans.J. Immunol.158199717721778","journal-title":"J. Immunol."},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.13.1.7598935"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80413-6"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.11.4378-4383.1997"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230923"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260722"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.11.4734-4737.1997"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00437195"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.223"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/315333a0"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.158.2.643","article-title":"Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells","volume":"158","author":"Piccotti J. R.","year":"1997","unstructured":"Piccotti J. R. Chan S. Y. Li K. Eichwald E. J. Bishop D. K. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells.J. Immunol.1581997643648","journal-title":"J. Immunol."},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.4049\/jimmunol.160.3.1132","article-title":"Alloantigen-reactive Th1 development in IL-12-deficient mice","volume":"160","author":"Piccotti J. R.","year":"1998","unstructured":"Piccotti J. R. Li K. Chan S. Y. Ferrante J. Magram J. Eichwald E. J. Bishop D. K. Alloantigen-reactive Th1 development in IL-12-deficient mice.J. Immunol.160199811321138","journal-title":"J. Immunol."},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.14.4515"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/208801a0"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/118.2.135"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.17.6808"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.6.1797"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00436496"},{"key":"e_1_3_1_47_2","first-page":"A1335","article-title":"Cell sources of natural killer cell stimulatory factor (NKSF\/IL-12) transcripts and subunit expression","volume":"6","author":"Wolf S.","year":"1992","unstructured":"Wolf S. Seiburth D. Perussia B. Yetz-Adalpe J. D\u2019Andrea A. Trinchieri G. Cell sources of natural killer cell stimulatory factor (NKSF\/IL-12) transcripts and subunit expression.FASEB J.61992A1335","journal-title":"FASEB J."},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2483"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.9.3594-3599.1997"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-2-234"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.66.10.4994-5000.1998","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.66.10.4994-5000.1998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T14:32:47Z","timestamp":1695565967000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.66.10.4994-5000.1998"}},"subtitle":[],"editor":[{"given":"S. H. E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1128\/IAI.66.10.4994-5000.1998"],"URL":"https:\/\/doi.org\/10.1128\/iai.66.10.4994-5000.1998","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]},"assertion":[{"value":"1998-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-07-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}